GSK nears $1bn deal for biotech developing drug for rare tumour
IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in US
Read more at Financial Times
Topics
-
In China, Rare Dissent Over a Program to Save on Drug Costs
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.The New York Times - 4h -
Sources: Chelsea near record deal for USWNT star
Chelsea are closing in on the signing of San Diego Wave centre-back Naomi Girma for a world-record fee exceeding $1 million.ESPN - 1d -
AI-developed drug will be in trials by year-end, says Google’s Hassabis
Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or neurodegeneration areasFinancial Times - 3d -
Israeli Cabinet Approves Gaza Deal as Hostage Release Draws Near
Netanyahu’s office says the cease-fire agreement will go into effect Sunday.The Wall Street Journal - 6d -
Hallucinations in AI: How GSK is addressing a critical problem in drug development
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.VentureBeat - Jan. 14 -
Israel and Hamas Near Agreement on Cease-Fire Deal, Qatar Says
The negotiations, mediated by Qatar, Egypt and the United States, appear to be making progress after months of failed attempts to achieve a breakthrough.The New York Times - Jan. 14 -
Israel and Hamas may be nearing ceasefire deal, sources say
A deal to end the war in Gaza could be close. An anonymous Israeli government official told CBS News the first phase of the ceasefire would last about 42 days with Hamas releasing 33 hostages in ...CBS News - Jan. 14 -
GSK to buy US cancer drug firm IDRx for up to $1.15bn
Massachusetts-based company is working on new treatments for gastrointestinal cancers. Business live – latest updates GSK has struck a deal worth up to $1.15bn (£950m) to acquire a ...The Guardian - Jan. 13 -
Nvidia invested $1bn in AI deals in 2024
Group emerges as crucial backer of start-ups seeking to gain from the tech revolution its chips are poweringFinancial Times - Jan. 1
More from Financial Times
-
Trump in fiery call with Denmark’s prime minister over Greenland
US president insisted he wants to take over Arctic islandFinancial Times - 15h -
Marco Rubio demands immediate halt to virtually all US foreign aid
Secretary of state freezes contracts around the world, fulfilling executive order from Donald TrumpFinancial Times - 12h -
Trump’s new economic war
The president’s ultimatums and demands on allies and rivals suggest he will use America’s financial might as a cudgelFinancial Times - 14h -
The podcast bros who helped put Trump back in the White House
Star presenters such as Joe Rogan and Theo Von have monetised the ‘manosphere’ and influenced politics. Will traditional media be next?Financial Times - 4h -
The revolt against over-management
In politics, media and sport, the advantages of looseness are becoming clearFinancial Times - 4h
More in Business
-
The revolt against over-management
In politics, media and sport, the advantages of looseness are becoming clearFinancial Times - 4h -
The podcast bros who helped put Trump back in the White House
Star presenters such as Joe Rogan and Theo Von have monetised the ‘manosphere’ and influenced politics. Will traditional media be next?Financial Times - 4h -
The waning of active funds is drying up the IPO market
The natural buyers of new equity have suffered relentless outflowsFinancial Times - 4h -
Pete Hegseth narrowly confirmed as Trump’s defence secretary
VP casts deciding vote after three Republican senators break ranks over claims of sexual abuse and excessive drinkingFinancial Times - 6h -
We're adding 4 stocks to our Bullpen watch list including a hot steakhouse chain
We're expanding our Bullpen following this week's January Monthly MeetingCNBC - 7h